hen the coronavirus pandemic broke out last year and the world clamoured for a vaccine to bring life back to normal, one company in western India was fully confident of playing a key role – indeed, it had spent years preparing for this very moment.
Serum Institute of India (SII), a family-run pharmaceutical giant that started out as a horse farm in the 1960s, is at the centre of the world’s crusade against Covid-19 thanks to its ability to produce over 1.6 billion vaccine doses per year. According to its owners – the billionaire Poonawalla family – its production capacity is unmatched anywhere in the world.
It is a testament to this that the Indian government’s vaccine rollout cannot keep up: even with the country exporting and gifting millions of doses to its neighbours and allies, SII is sitting on stockpiles of upwards of 55 million doses in cold storage.
Related posts:
Views: 0